Healthcare Sector and Stocks Analysis from Seeking Alpha
Wed, 19 Dec 2012
By EnhydrisPECorp : D-Day is fast-approaching for Hemispherx Biopharma's ( HEB ) New Drug Application for Ampligen, an anti-viral treatment indicated for use in patients suffering from chronic fatigue syndrome ( CFS ). The drug is slated to go before the FDA's Arthritis Advisory Committee on ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.